pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
411
stories
Jun 8, 26
STAT+: Novo underwhelmed by drug it once fought Pfizer for
stat
Jun 8, 26
STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
stat
Jun 8, 26
When it’s time to save a limb, novel clinic meets unhoused people where they are
stat
Jun 6, 26
STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug
stat
Jun 6, 26
Opinion: How the Amish think about vaccines, health care costs, and much more
stat
Jun 5, 26
CDC: Ebola outbreak in Central Africa could reach 20,000 cases without strong countermeasures
stat
Jun 5, 26
Study data convince Lundbeck to push new migraine drug forward
biopharma dive
Jun 5, 26
Generic drugmakers gain key victory in ‘skinny label’ patent case
biopharma dive
Jun 4, 26
STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial
stat
Jun 4, 26
STAT+: Utah Medical Board scolded for going rogue with AI criticism
stat
Jun 4, 26
An ADC specialist sinks on safety concerns for blood cancer drug
biopharma dive
Jun 4, 26
Otsuka showcases kidney drug data; Pfizer cuts an AI deal
biopharma dive
Jun 4, 26
Scientists uncover a new hiding spot for HIV
stat
Jun 4, 26
Opinion: Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story
stat
Jun 4, 26
Opinion: Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise
stat
Jun 3, 26
Legend surges on early data for ‘in vivo’ lymphoma cell therapy
biopharma dive
Jun 3, 26
Opinion: The medical-billing AI arms race between providers and insurance
stat
Jun 3, 26
Opinion: The Amish way of health care
stat
Jun 3, 26
Opinion: How the military may be fueling eating disorders in men
stat
Jun 2, 26
Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
biopharma dive
Jun 2, 26
Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
biopharma dive
Jun 2, 26
Opinion: The virtual end of the doctor’s office waiting room
stat
Jun 1, 26
STAT+: At the world’s largest cancer research meeting, data briefly took a backseat to grief
stat
Jun 1, 26
Servier buys into muscular dystrophy with potentially $2.7B deal
biopharma dive
Jun 1, 26
As FDA misses deadline on electric shock ban, disability advocates speak out
stat
Jun 1, 26
Opinion: What should hospitals do when patients demand unvaccinated donor blood?
stat
Jun 1, 26
Opinion: Medical schools diversified. So where are all the diverse doctors?
stat
Jun 1, 26
The hidden history of BPC-157, a favorite MAHA peptide
stat
May 31, 26
Akeso, Summit drug extends survival in closely watched lung cancer trial
biopharma dive
May 31, 26
‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer
biopharma dive
← prev
page 9 of 14
next →
